about
Evaluation of clonal origin of malignant mesotheliomaSequencing pools of individuals — mining genome-wide polymorphism data without big fundingIntratumor heterogeneity: evolution through space and timeGenetic Heterogeneity and Clonal Evolution of Tumor Cells and their Impact on Precision Cancer MedicineStress-triggered atavistic reprogramming (STAR) addiction: driving force behind head and neck cancer?Stem cell technology in breast cancer: current status and potential applicationsGenetic profiling of intrahepatic cholangiocarcinoma and its clinical implication in targeted therapyClonal origin and spread of metastatic prostate cancerPathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell VaccinationStem Cell Modeling of Core Binding Factor Acute Myeloid LeukemiaCancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesisExperimental evolution in biofilm populations.Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer TreatmentCancer Metabolism: A Modeling PerspectiveCurrent Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease RecurrenceTreatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsCharacterization of DNA Methylation in Circulating Tumor CellsGenomics of Cancer and a New Era for Cancer PreventionIs lineage decision-making restricted during tumoral reprograming of haematopoietic stem cells?Cancer stem cell targeted therapy: progress amid controversies.Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?The influence of subclonal resistance mutations on targeted cancer therapyCancer classification in the genomic era: five contemporary problemsStem cells in genetically-engineered mouse models of prostate cancerChallenges of deciphering gastric cancer heterogeneityBiological features and biomarkers in hepatocellular carcinomaProtecting the normal in order to better kill the cancerEvolutionary determinants of cancerThe 3' to 5' Exoribonuclease DIS3: From Structure and Mechanisms to Biological Functions and Role in Human DiseaseThe cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicineAcute myeloid leukaemia: a paradigm for the clonal evolution of cancer?Cancer heterogeneity--a multifaceted viewHeterogeneity and targeting of pancreatic cancer stem cellsGenetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapiesGlioblastoma cancer stem cells: Biomarker and therapeutic advancesAn expanding universe of the non-coding genome in cancer biologyTumour heterogeneity and the evolution of polyclonal drug resistanceIntratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasisHow animal models of leukaemias have already benefited patients
P2860
Q21146661-9966B2B2-1355-49D8-87DF-C904ACDA7815Q22121997-0CDB0049-1BA8-4C29-B90E-CBC16F39D8C0Q24598678-9403E9DD-C872-467B-B008-F13D62B69D0FQ24604479-CC775A03-11AE-461D-883B-2183787C8D6EQ26739748-4C294E28-3A05-4738-8CDA-2957A69AD397Q26746223-7085F175-D979-4A07-8222-03294309589FQ26751655-BE07E18E-260B-45A5-8F19-E678A9FAF457Q26752873-D702BA9D-19D0-4B6B-892B-51EECECA2A04Q26765345-0C79F7F2-37CA-4C3D-96D7-E8E8D7AD0B85Q26765858-E4163FFD-9843-4217-9CB2-D7D4D406B41FQ26766386-3AF5F18A-4534-4F1E-BAA5-622235229FE8Q26768691-8CB2D9AE-7204-48BF-A9F6-AE57058D6B54Q26769963-63145754-F426-4F54-A0F5-CC93B3EB7354Q26770819-51BF3C46-6D20-44A4-9C10-4648975B9FB8Q26774502-9C6B6E10-982D-4065-B26A-82E596EFADA2Q26776394-5282B93B-E7AC-4F11-B358-D8622B0425A0Q26778427-190217BA-842F-498E-8012-11E0AD92134CQ26779113-9E871D01-EDC3-49EB-A1BD-3204F5026427Q26779702-500942F1-8114-464B-91FE-9526D29410DAQ26779931-B2F97A8E-8200-4C57-969C-9354DC59F989Q26781271-E4A5DE4F-E79C-425E-BC77-6E8F43745BE0Q26781693-C4E2A1C7-71E4-4A06-97B0-67F19D7005A9Q26781783-723A1462-12CA-4013-A2B4-2BDADAD45176Q26784057-AEEE38CA-59B0-4846-AB26-496A9A3CC7FCQ26784448-E23FE020-E359-49BE-B83D-D6A486BAE837Q26799462-539A9366-630E-482C-A5B2-E89C50D0A7FFQ26801291-BE8DD51B-3D12-44BE-A000-F65E5A61A154Q26801710-2AB8D1D4-D10D-4409-A977-F41037A2B528Q26801730-BCF31E89-EA34-4244-BA9D-F1DEC136377BQ26824147-9FD77177-0540-4C10-9372-4C5109AA1BAEQ26825186-30E4F34D-9719-4211-94BF-72DCAA632C41Q26828997-3643C2FC-5DBA-440A-BC89-57C23C7D6E3BQ26829228-E5C9161C-D05F-4A17-9144-642A85854CE2Q26851734-163D73CB-23C7-4FAA-BABF-A4948319E8CBQ26852049-F8C5A6F7-5379-43B0-AEFB-6A0CC4330574Q26859782-9D3325A0-1ABB-4BA3-8C65-A3C420E00E20Q26865920-979F9A6A-C861-4D61-9CCF-3C4C21FADAABQ26866803-61EE7758-8E72-41B4-8B4B-B793426ABF99Q26991480-611B3787-F351-471B-9409-56793E2AA8F0Q26997702-A60AC99F-18EF-4A78-98B6-6A0C5945300A
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clonal evolution in cancer
@ast
Clonal evolution in cancer
@en
type
label
Clonal evolution in cancer
@ast
Clonal evolution in cancer
@en
prefLabel
Clonal evolution in cancer
@ast
Clonal evolution in cancer
@en
P2860
P3181
P356
P1433
P1476
Clonal evolution in cancer
@en
P2093
Carlo C Maley
P2860
P2888
P304
P3181
P356
10.1038/NATURE10762
P407
P577
2012-01-18T00:00:00Z
P5875
P6179
1053038796